150 related articles for article (PubMed ID: 2337578)
1. Effect of ionic strength and cationic DNA affinity binders on the DNA sequence selective alkylation of guanine N7-positions by nitrogen mustards.
Hartley JA; Forrow SM; Souhami RL
Biochemistry; 1990 Mar; 29(12):2985-91. PubMed ID: 2337578
[TBL] [Abstract][Full Text] [Related]
2. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards.
Mattes WB; Hartley JA; Kohn KW
Nucleic Acids Res; 1986 Apr; 14(7):2971-87. PubMed ID: 3960738
[TBL] [Abstract][Full Text] [Related]
3. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells.
Hartley JA; Bingham JP; Souhami RL
Nucleic Acids Res; 1992 Jun; 20(12):3175-8. PubMed ID: 1620613
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards.
Kohn KW; Hartley JA; Mattes WB
Nucleic Acids Res; 1987 Dec; 15(24):10531-49. PubMed ID: 3697095
[TBL] [Abstract][Full Text] [Related]
5. DNA sequence specificity of antitumor agents. Oncogenes as possible targets for cancer therapy.
Hartley JA; Lown JW; Mattes WB; Kohn KW
Acta Oncol; 1988; 27(5):503-10. PubMed ID: 2849464
[TBL] [Abstract][Full Text] [Related]
6. The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation.
Wyatt MD; Lee M; Hartley JA
Nucleic Acids Res; 1997 Jun; 25(12):2359-64. PubMed ID: 9171086
[TBL] [Abstract][Full Text] [Related]
7. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
Hartley JA; Gibson NW; Kohn KW; Mattes WB
Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
[TBL] [Abstract][Full Text] [Related]
8. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
[TBL] [Abstract][Full Text] [Related]
9. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
[TBL] [Abstract][Full Text] [Related]
10. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
11. N-(2-chloroethyl)-N-nitrosoureas covalently bound to nonionic and monocationic lexitropsin dipeptides. Synthesis, DNA affinity binding characteristics, and reactions with 32P-end-labeled DNA.
Church KM; Wurdeman RL; Zhang Y; Chen FX; Gold B
Biochemistry; 1990 Jul; 29(29):6827-38. PubMed ID: 2168742
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
13. Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove.
Brooks N; McHugh PJ; Lee M; Hartley JA
Chem Biol; 2000 Sep; 7(9):659-68. PubMed ID: 10980446
[TBL] [Abstract][Full Text] [Related]
14. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
15. DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
Prakash AS; Denny WA; Gourdie TA; Valu KK; Woodgate PD; Wakelin LP
Biochemistry; 1990 Oct; 29(42):9799-807. PubMed ID: 2271617
[TBL] [Abstract][Full Text] [Related]
16. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards.
Kohn KW; Hartley JA; Mattes WB
Biochem Pharmacol; 1988 May; 37(9):1799-800. PubMed ID: 3377838
[No Abstract] [Full Text] [Related]
18. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
Turner PR; Ferguson LR; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
[TBL] [Abstract][Full Text] [Related]
19. Concerted DNA recognition and novel site-specific alkylation by duocarmycin A with distamycin A.
Yamamoto K; Sugiyama H; Kawanishi S
Biochemistry; 1993 Feb; 32(4):1059-66. PubMed ID: 8424935
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and DNA-sequence selectivity of a series of mono- and difunctional 9-aminoacridine nitrogen mustards.
Kohn KW; Orr A; O'Connor PM; Guziec LJ; Guziec FS
J Med Chem; 1994 Jan; 37(1):67-72. PubMed ID: 8289202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
